CBU
DVAX

CIBC Bancorp USA’s Dynavax Technologies DVAX Stock Holding History

CIBC Bancorp USA’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$109K Buy
+11,002
New +$115K ﹤0.01% 1347

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

CIBC Bancorp USA's DVAX Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Dynavax Technologies (DVAX) in Q3 2025: 11,002 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #1347 among its holdings.

270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • CIBC Bancorp USA held 11,002 shares of Dynavax Technologies worth $109K as of Q3 2025.
  • Dynavax Technologies was a new CIBC Bancorp USA position in Q3 2025.
  • Dynavax Technologies made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1347 holding.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.